37 mg – The Thin Red Line Between Health and Harm in Medication Dosing

Time: 10:15 am - 10:35 am

Date: 24 April 2024

24-april-2024 10:15 24-april-2024 10:35 Europe/London 37 mg – The Thin Red Line Between Health and Harm in Medication Dosing

In 2023 the majority of available medication is still mass production and shelf medication. While gender science, weight and bioavailability differences, special needs in pediatric medication or psycho-actives in particular shows us, that a one-fits-all medication has overcome long since, pharmaceutical industry has still not turned direction. Personalized dosed medication is the future of health… Read more »

Making Pharmaceuticals

Synopsis

In 2023 the majority of available medication is still mass production and shelf medication. While gender science, weight and bioavailability differences, special needs in pediatric medication or psycho-actives in particular shows us, that a one-fits-all medication has overcome long since, pharmaceutical industry has still not turned direction.

Personalized dosed medication is the future of health treatment and a requirement of our time to improve side effects, reduce waste of pharmaceuticals and fight medication shortages.

Speakers

  • Ingo Krause Managing Partner - kg-pharma GmbH & Co. KG

« Back